Electronics manufacturer aims to develop device to treat retinal degeneration

被引：0
|
作者：
不详
机构：
来源：
EXPERT REVIEW OF MEDICAL DEVICES | 2004年 / 1卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R318 [生物医学工程];
学科分类号：
0831 ;
摘要：
引用
收藏
页码：5 / 5
页数：1
相关论文
共 38 条
  • [31] Safe SB100X transposase mRNA-mediated co-transfection of human RPE cells with two transposons coding for the neuroprotective factors PEDF and GM-CSF to treat retinal degeneration
    Bascuas, T.
    Harmening, N.
    Kropp, M.
    Mohit, M.
    Sealy, G.
    Follonier, A.
    Thumann, G.
    HUMAN GENE THERAPY, 2024, 35 (3-4) : A318 - A319
  • [32] Impact of Sub-Retinal Fluid on the Long-Term Incidence of Macular Atrophy in Neovascular Age-related Macular Degeneration under Treat & Extend Anti-Vascular Endothelial Growth Factor Inhibitors
    Siedlecki, Jakob
    Fischer, Cheryl
    Schworm, Benedikt
    Kreutzer, Thomas C.
    Luft, Nikolaus
    Kortuem, Karsten U.
    Schumann, Ricarda G.
    Wolf, Armin
    Priglinger, Siegfried G.
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [33] Impact of Sub-Retinal Fluid on the Long-Term Incidence of Macular Atrophy in Neovascular Age-related Macular Degeneration under Treat & Extend Anti-Vascular Endothelial Growth Factor Inhibitors
    Jakob Siedlecki
    Cheryl Fischer
    Benedikt Schworm
    Thomas C. Kreutzer
    Nikolaus Luft
    Karsten U. Kortuem
    Ricarda G. Schumann
    Armin Wolf
    Siegfried G. Priglinger
    Scientific Reports, 10
  • [34] Relationship between retinal fluid and visual acuity in patients with exudative age-related macular degeneration treated with intravitreal aflibercept using a treat-and-extend regimen: subgroup and post-hoc analyses from the ALTAIR study
    Masahito Ohji
    Annabelle A. Okada
    Koji Sasaki
    SungChul Charles Moon
    Tobias Machewitz
    Kanji Takahashi
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2021, 259 : 3637 - 3647
  • [35] Relationship between retinal fluid and visual acuity in patients with exudative age-related macular degeneration treated with intravitreal aflibercept using a treat-and-extend regimen: subgroup and post-hoc analyses from the ALTAIR study
    Ohji, Masahito
    Okada, Annabelle A.
    Sasaki, Koji
    Moon, SungChul Charles
    Machewitz, Tobias
    Takahashi, Kanji
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2021, 259 (12) : 3637 - 3647
  • [36] Correction to: Relationship between retinal fluid and visual acuity in patients with exudative age-related macular degeneration treated with intravitreal aflibercept using a treat-and-extend regimen: subgroup and post-hoc analyses from the ALTAIR study
    Masahito Ohji
    Annabelle A. Okada
    Koji Sasaki
    SungChul Charles Moon
    Tobias Machewitz
    Kanji Takahashi
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2022, 260 : 2395 - 2396
  • [37] Relationship between retinal fluid and visual acuity in patients with exudative age-related macular degeneration treated with intravitreal aflibercept using a treat-and-extend regimen: subgroup and post-hoc analyses from the ALTAIR study (vol 259, pg 3637, 2021)
    Ohji, Masahito
    Okada, Annabelle A.
    Sasaki, Koji
    Moon, SungChul Charles
    Machewitz, Tobias
    Takahashi, Kanji
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2022, 260 (07) : 2395 - 2396
  • [38] BASELINE CHARACTERISTICS OF THE FLUID STUDY PATIENTS: A RANDOMISED CLINICAL TRIAL INVESTIGATING THE NEED FOR COMPLETE RESOLUTION OF SUB-RETINAL FLUID (SRF) IN RANIBIZUMAB-TREATED PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION (NAMD) USING A TREAT AND EXTEND (T&E) REGIMEN
    Arnold, Jennifer
    Markey, Caroline
    Baird, Paul
    Richardson, Andrea
    Kurstjens, Nicol
    Guymer, Robyn
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2015, 43 : 108 - 108
1234